Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Apr 26;113(2):e2022022.
doi: 10.23749/mdl.v113i2.13017.

Serological response after SARS-CoV2 vaccination in healthcare workers: a multicenter study

Affiliations
Multicenter Study

Serological response after SARS-CoV2 vaccination in healthcare workers: a multicenter study

Giovanni Visci et al. Med Lav. .

Abstract

Introduction: Characterizing immunological response following COVID-19 vaccination is an important public health issue. The objectives of the present analysis were to investigate the proportion, level and the determinants of humoral response from 21 days to three months after the first dose in vaccinated healthcare workers (HCWs).

Methods: We abstracted data on level of anti-SARS-CoV-2 Spike antibodies (IgG) and sociodemographic characteristics of 17,257 HCWs from public hospitals and public health authorities from three centers in Northern Italy who underwent COVID-19 vaccination (average 70.6 days after first dose). We fitted center-specific multivariate regression models and combined them using random-effects meta-analyses.

Results: A humoral response was elicited in 99.3% of vaccinated HCW. Female sex, young age, and previous COVID-19 infection were predictors of post-vaccination antibody level, and a positive association was also detected with pre-vaccination serology level and with time between pre- and post-vaccination testing, while a decline of antibody level was suggested with time since vaccination.

Conclusions: These results stress the importance of analyzing retrospective data collected via occupational health surveillance of HCWs during the COVID-19 epidemic and following vaccination. They need to be confirmed in larger series based on prospectively collected data.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Li J, Concellón A, Yoshinaga K, Nelson Z, He Q, Swager TM. Janus Emulsion Biosensors for Anti-SARS-CoV-2 Spike Antibody. ACS Cent Sci. 2021;7:1166–75. - PMC - PubMed
    1. Thanh Le T, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19:305–6. - PubMed
    1. Graham BS. Rapid COVID-19 vaccine development. Science. 2020;368:945–6. - PubMed
    1. Chen X, Chen Z, Azman AS, et al. Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis. Clin Infect Dis. 2021:ciab646. - PMC - PubMed
    1. Baker MG, Peckham TK, Seixas NS. Estimating the burden of United States workers exposed to infection or disease: A key factor in containing risk of COVID-19 infection. PLoS One. 2020;15:e0232452. - PMC - PubMed

Publication types